<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757119</url>
  </required_header>
  <id_info>
    <org_study_id>L00008 CP 1 01</org_study_id>
    <secondary_id>2012-002190-63</secondary_id>
    <nct_id>NCT01757119</nct_id>
  </id_info>
  <brief_title>Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia</brief_title>
  <official_title>Study of the Pharmacokinetics of Serum Iron After Single Oral Administration of Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre Fabre Medicament</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pierre Fabre Medicament</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the pharmacokinetics of serum iron (the amount of
      iron in blood) after single oral administration of 2 tablets of L0008 80 mg (as ferrous
      sulphate) in women with iron deficiency anaemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pharmacokinetic profile of serum iron after single oral administration of ferrous sulphate supplement</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Pharmacokinetic profile of serum iron after single oral administration of ferrous sulphate supplement by measuring Maximum Plasma concentration, Time of Maximum Concentration, Area under the iron plasma concentration curve.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability of single administration (reported adverse events)</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Tolerability by evaluating the number of subjects with emergent adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Iron Deficiency Anemia</condition>
  <arm_group>
    <arm_group_label>Drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tardyferon 80 mg</intervention_name>
    <description>Oral administration (2 tablets)</description>
    <arm_group_label>Drug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women 18-45 years old with iron deficiency anaemia

          -  haemoglobin level between 85 g/L and 105 g/L

          -  serum ferritin level &lt; 15 Âµg/L

          -  D14 + 7 days of the menstruation cycle on the day of pharmacokinetic evaluation

          -  Standard diet

        Exclusion Criteria:

          -  - Anaemia related to other causes than iron deficiency and particularly inflammatory
             anaemia, anaemia due to marrow failure, haemopathy, haemoglobinopathies (sickle cell
             disease, thalassemia), haemolytic anaemia, anaemia due to acute haemorrhage, or
             anaemia related to chronic renal failure,

          -  Haemochromatosis or iron overload of secondary origin (blood transfusion),

          -  Long term treatment known to modify iron absorption,

          -  Gastro duodenal ulcer,

          -  Inflammatory bowel disease or any digestive disease which could modify iron
             absorption,

          -  Fructose intolerance, syndrome of malabsorption of glucose, galactose, deficit of
             sucrase-isomaltase,

          -  Serious or progressive disease (cardiac, pulmonary, hepatic, renal, haematological,
             malignancy, autoimmune disease, infectious disease or neuropsychiatric disorders),

          -  Surgery undergone within 1 month prior to selection visit or a surgery planned during
             the study realization.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Iasi</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Timisoara</city>
        <zip>300244</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2012</study_first_submitted>
  <study_first_submitted_qc>December 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2012</study_first_posted>
  <last_update_submitted>April 14, 2014</last_update_submitted>
  <last_update_submitted_qc>April 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Deficiency Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

